Chimeric (Mouse/Human) Anti-TNFRSF8 Recombinant Antibody (TAB-153) (CAT#: TAB-153)
This product is a human IgG1, κ antibody that can recognize human TNFRSF8.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
ELISA
Figure 1 Anti-Human CD30 Therapeutic Antibody (TAB-153) in ELISA
ELISA analysis of TAB-153 was performed by coating with Recombinant Human CD30 Protein. Then blocked with BSA, and incubated with Anti-Human CD30 Antibody (TAB-153). The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
ELISA
Figure 2 Chimeric (mouse/Human) Anti-TNFRSF8 Recombinant Antibody (TAB-153) in ELISA
ELISA analysis of TAB-153 was performed by coating with CD30, Human, Recombinant.
The secondary antibody: HRP-Anti-Human IgG (H+L)
Specifications
- Immunogen
- Hodgkin's lymphoma cell line L428.
- Host Species
- Human
- Derivation
- Chimeric (Mouse/Human)
- Type
- Human IgG1, κ
- Specificity
- Human TNFRSF8
- Species Reactivity
- Human
- Applications
- Neut, ELISA, IF, IP, FuncS, FC, ICC
Product Property
- Purification
- Protein A/G Purified
- Purity
- >95% as determined by SDS-PAGE and HPLC analysis
- Concentration
- Please refer to the vial label for the specific concentration
- Buffer
- PBS
- Preservative
- No preservatives
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- This antibody has been reported for use in Neutralization, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Immunoprecipitation, Functional Assay, Flow Cytometry, Immunocytochemistry.
Target
- Alternative Names
- CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; cytokine receptor CD30; lymphocyte activation antigen CD30
- Gene ID
- 943
- UniProt ID
- P28908
Related Resources
Please refer to Brentuximab Vedotin Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Brentuximab Vedotin.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "TNFRSF8"
Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products
Immunotoxin Products
Humanized Antibody Products
Fc Glycosylation Antibody Products
Low- or Non-fucosylated Oligosaccharide Antibody Products
Chicken IgY Antibody Products
Blocking Antibody Products
Neutralizing Antibody Products
Rabbit Monoclonal Antibody Products
IgG Antibody Products
ScFv Antibody Products
Fab Antibody Products
ADCC Enhanced Antibody Products
Agonistic Antibody Products
ScFv-Fc Chimera Products
Flow Cytometry (FC) related Reagents and Kits: Empowering Cell Function Research
Extracellular Vesicle (EV) Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-144 | Anti-Human CD30 Recombinant Antibody (Iratumumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 - kappa |
Customer Reviews and Q&As
Customer Review
Q&As
Great for Flow Cytometry Applications
We have successfully integrated the Anti-TNFRSF8 antibody into our flow cytometry protocols, where its high specificity and sensitivity have provided us with reliable data on CD30 expression, enhancing our understanding of various cellular processes involved in lymphoma progression.
Effective in Lymphoma Research
The Anti-TNFRSF8 Recombinant Antibody has been a fundamental asset in our lymphoma research. Its precision in detecting CD30 expression has allowed us to gain significant insights into the malignancy's behavior and the tumor microenvironment, paving the way for potential therapeutic applications.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-153, RRID: AB_3111839)
Copy citation
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
-3.jpg)
Application: Neut
Application: ELISA, Neut
-3.jpg)
Application: ELISA, WB
-2.png)
Application: ELISA, WB
Application: ELISA, FC
Application: Inhib, FC, WB
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
